Screener

Noncash Advance Future Royalties Interest Expense

Name: AnaptysBio, Inc. Noncash Advance Future Royalties Interest Expense by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

AnaptysBio, Inc.·Business Segments·2 segments·Rolls up to Noncash Advance Future Royalties Interest Expense

Breakdown

Segment	Q1 '26
Royalty Management Company	$20.86M
Biopharma Company	$0
Total	$20.86M

Segments

Biopharma CompanyView metric

Royalty Management CompanyView metric